Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Incyte Corporation - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
INCY
Nasdaq
8731
http://www.incyte.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Incyte Corporation
Incyte to Present at Upcoming Investor Conference
- Apr 26th, 2018 6:00 am
Incyte Highlights Abstracts Accepted for Presentation at the 2018 ASCO Annual Meeting
- Apr 25th, 2018 3:38 pm
Lessons to Learn From April's Biotech Blowups
- Apr 25th, 2018 8:33 am
Today's Research Reports on Trending Tickers: Allergan and Incyte Corporation
- Apr 25th, 2018 6:30 am
Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug
- Apr 24th, 2018 9:59 am
Eli Lilly, Incyte shares drop after mixed FDA drug recommendation
- Apr 24th, 2018 5:30 am
Eli Lilly's earnings beat expectations, and its improved outlook overcomes regulatory setback
- Apr 24th, 2018 5:03 am
FDA Advisory Committee Recommends the Approval of Baricitinib 2mg, but not 4mg, for the Treatment of Moderately-to-Severely Active Rheumatoid Arthritis
- Apr 23rd, 2018 6:10 pm
FDA panel against higher dose of Lilly-Incyte arthritis drug
- Apr 23rd, 2018 4:44 pm
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Incyte Corporation (INCY)
- Apr 20th, 2018 8:54 am
3 Biotech Stocks With Major Catalysts Incoming
- Apr 20th, 2018 6:03 am
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Incyte Corporation - INCY
- Apr 19th, 2018 3:27 pm
Eli Lilly's Blockbuster Resurrection Story Has Holes
- Apr 19th, 2018 12:09 pm
Gilead shares drop on FDA concerns with similar Eli Lilly, Incyte drug
- Apr 19th, 2018 12:01 pm
Eli Lilly, Incyte shares fall after FDA cites issues with rheumatoid arthritis drug
- Apr 19th, 2018 7:10 am
FDA staff cites safety issues for Lilly, Incyte's rheumatoid arthritis drug
- Apr 19th, 2018 6:15 am
What Incyte's Phase 3 Fail Means for Immuno-Oncology
- Apr 16th, 2018 3:01 pm
NewLink Shares Bite The Dust After Merck-Incyte Melanoma Failure
- Apr 16th, 2018 2:21 pm
What's Next for Incyte?
- Apr 16th, 2018 2:16 pm
NewLink shares fall on late-stage trial changes
- Apr 16th, 2018 6:48 am
Scroll